Mechanisms of TET2 Epigenetics in Myeloid Cancers - K Helin
24:25
Challenges in MDS Diagnosis
15:18
SRSF2 P95H Initiates Myeloid Bias and MDS/MPN from Haematopoietic Stem Cells - M Smeets
58:56
Discovery of MTA-Cooperative PRMT5 Inhibitors for the Treatment of MTAP-Deleted Cancer.
37:03
Connecting Genetic and Transcriptional Variation in Acute Myeloid Leukemia at Single-Cell Resolution
20:33
Pre MDS states CH, CCUS, ICUS – How to manage in the clinic?
24:20
2024 FSS at ASH - Who Should be Tested for the Presence of Myeloid Predisposition Mutations?
1:26:15
Updates on MDS Classifications
19:30